By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has raised £11.3 million ($18.6 million) in a Series C round of financing.

The Cambridge, UK-based maker of research tools for personalized medicine and drug discovery said that the funds will be used to improve its core technology platforms, strengthen its intellectual property position, and expand into new disease areas outside of its historical focus on cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.